New findings presented at AOCN 2021 have highlighted additional mortality risks associated with long-term use of hypnotics/sedatives in people with short- or long-duration sleep.
The interplay of health risks between hypnotic/sedative use and sleep duration is not clear. To shed light on this, Dr Yu Sun of the En Chu Kong Hospital, New Taipei City, Taiwan, performed a study to measure the mortality risks among users of hypnotics/sedatives with different sleep durations.
The study included 484,916 community-dwelling adults (mean age 40.3±13.5 years, 52.2% women) who were recruited in a health screening program from January 1994 to December 2011.